BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,287,341 | -0.4% | 2,017,986 | -1.0% | 0.16% | +10.0% |
| Q2 2023 | $14,345,324 | +93495.1% | 2,037,688 | +10.9% | 0.15% | -9.1% |
| Q1 2023 | $15,327 | -20.0% | 1,837,854 | +10.1% | 0.16% | -22.9% |
| Q4 2022 | $19,160 | -99.9% | 1,668,999 | -0.7% | 0.21% | -15.1% |
| Q3 2022 | $21,182,000 | +9.8% | 1,681,189 | -7.8% | 0.25% | +16.1% |
| Q2 2022 | $19,292,000 | +25.7% | 1,823,209 | +93.2% | 0.22% | +47.6% |
| Q1 2022 | $15,346,000 | – | 943,792 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |